Arend RC, Monk BJ, Shapira-Frommer R, Haggerty AF, et al. Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018). J Clin Oncol 2023 Oct 31:JCO2202915. doi: 10.1200/JCO.22.02915.
PMID: 37906726